Siva Uppalapati
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bacterial Toxins | 6 | 2019 | 106 | 1.680 |
Why?
| Type C Phospholipases | 4 | 2015 | 72 | 1.370 |
Why?
| Calcium-Binding Proteins | 4 | 2015 | 210 | 1.260 |
Why?
| Salmonella Phages | 1 | 2024 | 3 | 0.900 |
Why?
| Prophages | 1 | 2024 | 7 | 0.900 |
Why?
| Endodeoxyribonucleases | 1 | 2024 | 67 | 0.850 |
Why?
| Salmonella enterica | 1 | 2024 | 55 | 0.850 |
Why?
| Hemolysin Proteins | 2 | 2014 | 34 | 0.830 |
Why?
| Clostridium perfringens | 4 | 2015 | 5 | 0.790 |
Why?
| Viral Proteins | 1 | 2024 | 328 | 0.740 |
Why?
| Clostridium Infections | 3 | 2015 | 64 | 0.580 |
Why?
| Recombinant Fusion Proteins | 3 | 2015 | 643 | 0.510 |
Why?
| Bacterial Vaccines | 2 | 2015 | 62 | 0.460 |
Why?
| Molecular Dynamics Simulation | 1 | 2013 | 217 | 0.380 |
Why?
| Staphylococcal Infections | 2 | 2014 | 393 | 0.350 |
Why?
| Mice, Inbred BALB C | 6 | 2019 | 1245 | 0.340 |
Why?
| Polymerase Chain Reaction | 3 | 2014 | 1038 | 0.330 |
Why?
| Oxidative Stress | 2 | 2024 | 1269 | 0.270 |
Why?
| NADPH Oxidases | 2 | 2024 | 108 | 0.270 |
Why?
| Staphylococcus aureus | 2 | 2014 | 438 | 0.230 |
Why?
| Phagocytes | 1 | 2024 | 97 | 0.210 |
Why?
| Methionine | 1 | 2024 | 158 | 0.210 |
Why?
| Protein Structure, Tertiary | 3 | 2015 | 840 | 0.210 |
Why?
| RNA, Transfer | 1 | 2024 | 130 | 0.210 |
Why?
| Salmonella | 1 | 2023 | 59 | 0.200 |
Why?
| Antibodies, Bacterial | 4 | 2019 | 137 | 0.200 |
Why?
| Immunity, Innate | 2 | 2017 | 804 | 0.170 |
Why?
| Animals | 9 | 2024 | 35361 | 0.160 |
Why?
| RNA | 1 | 2024 | 883 | 0.140 |
Why?
| Erythrocytes | 2 | 2013 | 672 | 0.140 |
Why?
| Immunization, Passive | 2 | 2015 | 87 | 0.140 |
Why?
| Herpes Simplex | 1 | 2017 | 93 | 0.130 |
Why?
| Herpesvirus 1, Human | 1 | 2017 | 86 | 0.130 |
Why?
| Shigella | 1 | 2015 | 4 | 0.120 |
Why?
| Chaperonin 60 | 1 | 2015 | 14 | 0.120 |
Why?
| Dysentery, Bacillary | 1 | 2015 | 9 | 0.120 |
Why?
| Enterotoxins | 1 | 2015 | 89 | 0.120 |
Why?
| Vaccines, Subunit | 1 | 2015 | 48 | 0.120 |
Why?
| Aspergillus flavus | 1 | 2014 | 1 | 0.110 |
Why?
| Recombinant Proteins | 2 | 2015 | 1304 | 0.110 |
Why?
| Mice | 6 | 2024 | 16937 | 0.110 |
Why?
| Static Electricity | 1 | 2013 | 116 | 0.110 |
Why?
| Injections, Intramuscular | 1 | 2013 | 116 | 0.110 |
Why?
| Interleukin-1 | 1 | 2017 | 958 | 0.100 |
Why?
| Fusarium | 1 | 2013 | 4 | 0.100 |
Why?
| Penicillium | 1 | 2013 | 6 | 0.100 |
Why?
| Aspergillus | 1 | 2013 | 15 | 0.100 |
Why?
| Immunoglobulin G | 2 | 2015 | 847 | 0.100 |
Why?
| Immunity, Cellular | 1 | 2015 | 265 | 0.100 |
Why?
| Th2 Cells | 1 | 2014 | 171 | 0.100 |
Why?
| Food Contamination | 1 | 2013 | 44 | 0.100 |
Why?
| Necrosis | 1 | 2013 | 232 | 0.100 |
Why?
| Food Microbiology | 1 | 2013 | 61 | 0.100 |
Why?
| Immune Sera | 1 | 2012 | 86 | 0.100 |
Why?
| Multiplex Polymerase Chain Reaction | 1 | 2013 | 51 | 0.100 |
Why?
| HeLa Cells | 1 | 2014 | 608 | 0.100 |
Why?
| Hemolysis | 1 | 2013 | 199 | 0.100 |
Why?
| Gene Expression | 2 | 2015 | 1472 | 0.100 |
Why?
| Interleukin-10 | 1 | 2014 | 304 | 0.100 |
Why?
| Binding Sites | 1 | 2013 | 1252 | 0.090 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 833 | 0.080 |
Why?
| Blotting, Western | 1 | 2012 | 1205 | 0.080 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2014 | 1198 | 0.080 |
Why?
| Bacterial Proteins | 1 | 2015 | 835 | 0.080 |
Why?
| DNA Primers | 2 | 2013 | 510 | 0.070 |
Why?
| Protein Binding | 1 | 2013 | 2121 | 0.070 |
Why?
| Female | 6 | 2019 | 68776 | 0.060 |
Why?
| Anaerobiosis | 1 | 2024 | 57 | 0.050 |
Why?
| Muscle, Skeletal | 1 | 2013 | 1614 | 0.050 |
Why?
| DNA, Fungal | 2 | 2014 | 74 | 0.050 |
Why?
| Respiration | 1 | 2024 | 191 | 0.050 |
Why?
| Survival Analysis | 2 | 2017 | 1274 | 0.050 |
Why?
| Salmonella typhimurium | 1 | 2024 | 175 | 0.050 |
Why?
| Burkholderia pseudomallei | 1 | 2019 | 10 | 0.040 |
Why?
| A549 Cells | 1 | 2019 | 59 | 0.040 |
Why?
| Oxidation-Reduction | 1 | 2023 | 1033 | 0.040 |
Why?
| Protein Domains | 1 | 2019 | 253 | 0.040 |
Why?
| Humans | 7 | 2024 | 129650 | 0.040 |
Why?
| Glucose | 1 | 2023 | 1003 | 0.040 |
Why?
| Adaptive Immunity | 1 | 2017 | 161 | 0.030 |
Why?
| Disease Models, Animal | 2 | 2017 | 4063 | 0.030 |
Why?
| Salmonella typhi | 1 | 2015 | 13 | 0.030 |
Why?
| Caco-2 Cells | 1 | 2015 | 75 | 0.030 |
Why?
| Aflatoxins | 1 | 2014 | 3 | 0.030 |
Why?
| Cloning, Molecular | 1 | 2015 | 524 | 0.030 |
Why?
| Adjuvants, Immunologic | 1 | 2015 | 221 | 0.030 |
Why?
| Immunoglobulin A | 1 | 2015 | 200 | 0.030 |
Why?
| Ochratoxins | 1 | 2013 | 2 | 0.030 |
Why?
| Mycotoxins | 1 | 2013 | 3 | 0.030 |
Why?
| Fumonisins | 1 | 2013 | 3 | 0.030 |
Why?
| Trichothecenes | 1 | 2013 | 4 | 0.030 |
Why?
| Microsatellite Repeats | 1 | 2014 | 164 | 0.030 |
Why?
| Skin | 1 | 2017 | 725 | 0.020 |
Why?
| Immunization | 1 | 2015 | 411 | 0.020 |
Why?
| Cytokines | 1 | 2019 | 2017 | 0.020 |
Why?
| Interferon-gamma | 1 | 2015 | 770 | 0.020 |
Why?
| T-Lymphocytes | 1 | 2019 | 1928 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2015 | 2058 | 0.020 |
Why?
| Escherichia coli | 1 | 2015 | 774 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2013 | 582 | 0.020 |
Why?
| Mice, Knockout | 1 | 2017 | 2871 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2015 | 2832 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 1838 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2015 | 3215 | 0.020 |
Why?
|
|
Uppalapati's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|